Concepedia

Matthias Hoffmann

MH

8

Publications

2.3K

Citations

8

H-Index

1998

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (Austria)

Research Institute of Molecular Pathology

Matthias Hoffmann is an author at Boehringer Ingelheim (Germany) specializing in medicine, natural sciences, and cell biology.

Top concepts

Publications per year

1998–2016

8

Publications

8

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo

Martin Steegmaier, Matthias Hoffmann, Anke Baum et al. · Current Biology · 2007 · 839 citations · Full text

, , +9

The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1

Péter Lénárt, Mark Petronczki, Martin Steegmaier et al. · Current Biology · 2007 · 675 citations · Full text

, , +12

BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity

Dorothea Rudolph, Martin Steegmaier, Matthias Hoffmann et al. · Clinical Cancer Research · 2009 · 388 citations · Full text

BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms<i>in vitro</i>and<i>in vivo</i>

Gopal P. Sapkota, Lorna Cummings, Felicity Newell et al. · Biochemical Journal · 2006 · 301 citations · Full text

, , +21

The laccase gene family in Coprinopsis cinerea (Coprinus cinereus)

Patrik J. Hoegger, Monica Navarro-Gonz�lez, Sreedhar Kilaru et al. · Current Genetics · 2003 · 62 citations · Full text

Rows per page

1–5 of 8